Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,259 | 2,584 | 2,778 | 2,716 | 2,586 |
| Receivables | 1,195 | 777 | 740 | 848 | 1,143 |
| Other current assets | 1,090 | 1,601 | 1,689 | 2,183 | 2,539 |
| TOTAL | $6,070 | $5,547 | $5,713 | $6,208 | $6,785 |
| Non-Current Assets | |||||
| PPE Net | 2,822 | 3,365 | 3,845 | 4,319 | 4,667 |
| Intangibles | 696 | 687 | 3,159 | 681 | 667 |
| Other Non-Current Assets | 4,537 | 5,320 | 2,922 | 5,267 | 2,745 |
| TOTAL | $8,055 | $9,372 | $9,926 | $10,267 | $8,079 |
| Total Assets | $14,125 | $14,919 | $15,639 | $16,475 | $14,864 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,739 | 1,000 | 1,083 | 1,000 | 1,000 |
| Accounts payable and accrued liabilities | 835 | 335 | 283 | 480 | 271 |
| Accrued Expenses | 1,078 | 772 | 1,004 | 820 | 1,016 |
| Other current liabilities | 419 | 171 | 231 | 198 | 337 |
| TOTAL | $6,095 | $3,532 | $3,574 | $4,057 | $4,024 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,987 | 2,235 | 2,482 | 2,729 |
| Deferred Revenues | 460 | 743 | 518 | 1,194 | 1,267 |
| Other Non-Current Liabilities | 2,917 | 3,017 | 3,115 | 3,186 | 0 |
| TOTAL | $2,939 | $5,042 | $5,398 | $5,727 | $3,923 |
| Total Liabilities | $9,034 | $8,574 | $8,972 | $9,784 | $7,947 |
| Shareholders' Equity | |||||
| Common Shares | 14 | 14 | 14 | 14 | 14 |
| Retained earnings | -131,457 | -130,156 | -129,805 | -129,707 | -129,394 |
| Other shareholders' equity | -187 | -208 | -190 | -222 | -255 |
| TOTAL | $5,091 | $6,345 | $6,667 | $6,691 | $6,917 |
| Total Liabilities And Equity | $14,125 | $14,919 | $15,639 | $16,475 | $14,864 |